Showing 3 posts of 3 posts found.


Autifony announces global license and collaboration agreement with Jazz Pharmaceuticals

November 14, 2023
Business Services Autifony, Neurology, collaboration, jazz pharmaceuticals, neurological disorders

Autifony Therapeutics has announced that it has entered an exclusive global licensing agreement with Jazz Pharmaceuticals for up to $770.5m, …

Boehringer scoops schizophrenia candidates for €627.5m

December 19, 2017
Manufacturing and Production, Sales and Marketing Autifony, Boehringer Ingelheim, biotech, drugs, pharma, pharmaceutical

Boehringer Ingelheim has moved early to secure an exclusive option on Autifony’s lead candidate for the treatment of schizophrenia, AUT00206, …


GSK invests in UK biotech start-up

August 22, 2011
Research and Development Autifony, GSK, biotech, hearing loss, research and development news

GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …

Latest content